287 related articles for article (PubMed ID: 14750079)
1. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
3. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
[TBL] [Abstract][Full Text] [Related]
4. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
5. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
Ozdemir E; Akgedik K; Akdogan S; Kansu E
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
[TBL] [Abstract][Full Text] [Related]
6. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
[TBL] [Abstract][Full Text] [Related]
7. Post-thaw viability of cryopreserved hematopoietic progenitor cell grafts: does it matter?
Vrhovac R; Perić Z; Jurenec S; Kardum-Skelin I; Jelić-Puskarić B; Jaksić B
Coll Antropol; 2010 Mar; 34(1):163-9. PubMed ID: 20432746
[TBL] [Abstract][Full Text] [Related]
8. Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations.
Foïs E; Desmartin M; Benhamida S; Xavier F; Vanneaux V; Rea D; Fermand JP; Arnulf B; Mounier N; Ertault M; Lotz JP; Galicier L; Raffoux E; Benbunan M; Marolleau JP; Larghero J
Bone Marrow Transplant; 2007 Nov; 40(9):831-5. PubMed ID: 17724443
[TBL] [Abstract][Full Text] [Related]
9. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
Kim DH; Jamal N; Saragosa R; Loach D; Wright J; Gupta V; Kuruvilla J; Lipton JH; Minden M; Messner HA
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1233-43. PubMed ID: 17889361
[TBL] [Abstract][Full Text] [Related]
10. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.
Allan DS; Keeney M; Howson-Jan K; Popma J; Weir K; Bhatia M; Sutherland DR; Chin-Yee IH
Bone Marrow Transplant; 2002 Jun; 29(12):967-72. PubMed ID: 12098064
[TBL] [Abstract][Full Text] [Related]
11. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
[TBL] [Abstract][Full Text] [Related]
12. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P
Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022
[TBL] [Abstract][Full Text] [Related]
15. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment.
Beaujean F; Bourhis JH; Bayle C; Jouault H; Divine M; Rieux C; Janvier M; Le Forestier C; Pico JL
Bone Marrow Transplant; 1998 Dec; 22(11):1091-6. PubMed ID: 9877272
[TBL] [Abstract][Full Text] [Related]
16. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing.
Rodríguez L; Velasco B; García J; Martín-Henao GA
Transfusion; 2005 Aug; 45(8):1391-7. PubMed ID: 16078930
[TBL] [Abstract][Full Text] [Related]
18. Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2x10(6) CD34+ cells/kg.
Abrahamsen JF; Wentzel-Larsen T; Bruserud O
Cytotherapy; 2004; 6(4):356-62. PubMed ID: 16146888
[TBL] [Abstract][Full Text] [Related]
19. Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples.
Laroche V; McKenna DH; Moroff G; Schierman T; Kadidlo D; McCullough J
Transfusion; 2005 Dec; 45(12):1909-16. PubMed ID: 16371043
[TBL] [Abstract][Full Text] [Related]
20. Clinical side effects during peripheral blood progenitor cell infusion.
Donmez A; Tombuloglu M; Gungor A; Soyer N; Saydam G; Cagirgan S
Transfus Apher Sci; 2007 Feb; 36(1):95-101. PubMed ID: 17236813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]